СУРУНКАЛИ БУЙРАК КАСАЛЛИГИ БИЛАН ОҒРИГАН БЕМОРЛАРДА ПАРОДОНТ КАСАЛЛИКЛАР ВА ОҒИЗ ШИЛЛИҚ ҚАВАТИНИНГ КЛИНИК КЕЧИШИ ВА ПАЙДО БЎЛИШ ЧАСТОТАСИНИНГ ХУСУСИЯТЛАРИ
##article.subject##:
буйрак трансплантацияси, гипероксалурия, уратурия, сурункали буйрак етишмовчилиги, сурункали генераллашган пародонтит##article.abstract##
Буйрак трансплантациясининг гемодиализ билан солиштирганда умр кўриш давомийлиги ва унинг сифати, шунингдек, иқтисодий жиҳатдан муҳим афзалликлари уни танлаш усулига айлантиради, айниқса нисбатан ёш беморларда. Буйрак трансплантацияси учун кўрсатмалар баёноти трансплантация бўйича жарроҳ ва нефролог ёки уролог (ёки / ва педиатр) томонидан биргаликда амалга оширилади. Бундай беморлар одатда сурункали диализли беморлардир. Буйрак трансплантациясидан кейин соглом даражаси 95% дан ошади ва 3-6 ой ичида уни рад этиш еҳтимоли. Гемодиализдан фойдаланмасдан ёки ундан олдин буйрак трансплантацияси имкониятлари мавжуд, бу тирик донордан (тирик donor) профилактик буйрак трансплантацияси деб аталади.
Библиографические ссылки
Ariyamuthu, V. Periodontal Disease in Chronic Kidney Disease and End- Stage Renal Disease Patients: A Review / V. Ariyamuthu, K. Nolph, B. Ringdahl // Cardiorenal Med. - 2013. - № 3. - pp. 71 - 78.
Antiviral properties of lactoferrin-a natural immunity molecule / F. Berlutti, F. Pantanella, T. Natalizi, A. Frioni, R. Paesano, A. Polimeni, P. Valenti // Molecules. - 2011. - Vol. 16. - pp. 6992-7018.
Antoniades, D. Z. Ulcerative uremic stomatitis associated with untreated chronic renal failure: report of a case and review of the literature / D. Z. Antoniades // Oral Surg Oral Med Oral Pathol Oral RadiolEndod. - 2006. - Vol. 101, № 5. - pp. 608-613.
Arslan, S. Y The effect of lactoferrin on oral bacterial attachment / S. Y. Arslan, K. P. Leung, C. D. Wu // Oral Microbiol Immunol. - 2009. - Vol. 24. - P. 6411.
Adrissino, G., Dacco V., Testa S. et al. Epidemiology of chronic renal failure in children: Date from the ItalKid Project // Pediatrics. 2003. - Vol. 111. — pp. 1382-1387.
Akbari, A. Detection of chronic kidney disease with laboratory reporting of estimated glomerular filtration rate and an educational program / A. Akbari, P.J. Swedko, H.D. Clark, W. Hogg, J. Lemelin, P. Magner et al. // Arch Intern Med. 2004. Vol. 164. pp. 1788-1792.
Arpegard, J., Ostergren J., de Faire U. et al. Cystatin C - marker of peripheral atherosclerotic disease // Atherosclerosis. 2008. Vol. 199 (2). pp. 397-401.
Bastos, J.A. Identification of periodontal pathogens and severity of periodontitis in patients with and without chronic kidney disease. / J.A. Bastos, C.G. Diniz, M.G. Bastos [et. al] //Archives of Oral Biology. - 2011. - № 56 (8). - pp. 804 - 811.
Brossard, J. H. Influence of glomerular filtration rate on non-(1-84) parathyroid hormone detected by intact PTH assays / J. H. Brossard, R. Lepage, H. Cardinal [et al] // Clin. Chem. - 2000.-46. - pp. 697-703.
Bottinger, E.P. TGF-beta signaling in renal disease / E.P. Bottinger, M. Bitzer // J Am Soc Nephrol. 2002. Vol. 13. pp. 2600-2610.
Bokenkamp, A. Reference values for cystatin C serum concentrations in children/ A.Bokenkamp, M. Domanetzki, R. Zinck et al. // Pediatr Nephrol. 1998. Vol.12 - pp. 125-129.
Bangstad H-J, Seljeflot I, Berg T.J. Renal tubulointerstitial expansion is associated with endothelial dysfunction and inflammation in type 1 diabetes.
Devarajan, P. The Use of Targeted Biomarkers for Chronic Kidney Disease / P. Devarajan // Advances in chronic kidney disease. - 2010. - Vol. 14. - P. 469.
Scandinavian Journal of Clinical and' Laboratory Investigation. 2009; 69, 1, P: 138- 144(7)
Burton C. Y.,Combe C., Walls J., Harris K.P. Secreciyn of chemokins and cytokins by human tubular epithelial cells in response to proteins.// Nephrol. Dial. Transplant. - 1999. - Vol. 14. - №11. - p. 2628-2633
Becker R.H., Dahmen R., Bergmann K. et al. (2015) New insulin glargin 300 U.mL 1 provides a more even activity profile and prolonged glycemic control at steady state compared with insulin glargine 100 U.ml 1. Diabetes Care, 38: 637–643.
Biesenbach G., Raml A., Schmekal B., Eichbauer-Sturm G. (2003) Decreased insulin requirement in relation to GFR in nephropathic Type 1 and insulin-treated Type 2 diabetic patients. Diabet. Med., 20(8): pp. 642–645.
Bolli G.B., Riddle M.C., Bergenstal R.M. et al. (2015) New insulin glargine 300 U/ml compared with glargine 100U/ml in insulin naїve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3). Diabetes Obes. Metab., 17: pp. 386–394.
Conti, M. Urinary cystatin C as a specific marker of tubular dysfunction / M. Conti, S. Moutereau, M. Zater, M. K. Lallali, A. Durrbach, P. Manivet, P. Eschwege, S. Loric // Clin Chem Lab Med. 2006. Vol. 44. pp. 288-291
Cale С. M. Cytokines and macrophages: implications for normal and abnormal renal development / С. M. Cale // Pediatr. Nephrology. 1999. -Vol. 13. - pp. 709-715.
Craig, R. G. Periodontal therapy is associated with decreased risk of developing end-stage renal disease—a study using the Taiwan National Health Insurance Database // Evid. Based Dent. Pract. - 2014. - № 14 (2). -pp. 62 - 64.
Craig, R.G. Periodontitis and the end-stage renal disease patient receiving hemodialysis maintenance therapy / R.G. Craig, P. Kotanko // Compend. Contin. Educ. Dent. - 2009 - № 30(8) - pp. 544-549.
ChevalierR.L., Goyal S., Kim A., Chang A.Y., Landau D., LeRoith D. Renal tubulointerstitial injury from ureteral obstruction in the neonatal rat is attenuated by IGF-1 .//Kidney Int. - 2000. -Vol.57. - №3. - p.882-890
Chiaramonte C., Cigna R.M., Cataliotti F. Microproteinuria as a marker of renal damage in children // Minerva Urol Nefrol.- 2002.- v.54, №4.- pp.237-242.
Choi Y.J., Chakraborty S., Nguyen V., Nguyen C., Kim B. K., Shim S.I.., Suki W.N., Truong, L.D. Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: altered expression of vascular endothelial growth factor.//Hum. Pathol. - 2000. - Vol.31. - №12. - pp. 1491—1497
Chertin B., Natsheh A., Fridmans A. et al. Renal scarring and urinary tract infection after endoscopic correction of vesicoureteral reflux // J. Urol. 2009. Vol. 182 (4). pp. 1706-1707.
Docherty, N. G. Transforming growth factor-beta (TGF-beta): a potential recovery signal in the post-ischemic kidney / N. G. Docherty, F. Perez-Barriocanal, N. E. Balboa, J. M. Lopez-Novoa // Ren Fail. 2002. - Vol.24. - №4.- pp.391-406.
Devarajan, P. The Use of Targeted Biomarkers for Chronic Kidney Disease / P. Devarajan // Advances in chronic kidney disease. - 2010. - Vol. 14. - P. 469.
